| Design and synthesis of thiazolidine-2, 4-diones hybrids with 1, 2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: In-vitro anticancer evaluation and in … MS Taghour, H Elkady, WM Eldehna, NM El-Deeb, AM Kenawy, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 1903-1917, 2022 | 74 | 2022 |
| Pimenta dioica (L.) Merr. Bioactive Constituents Exert Anti-SARS-CoV-2 and Anti-Inflammatory Activities: Molecular Docking and Dynamics, In Vitro, and In Vivo … HA El Gizawy, SA Boshra, A Mostafa, SH Mahmoud, MI Ismail, AA Alsfouk, ... Molecules 26 (19), 5844, 2021 | 73 | 2021 |
| In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10 IH Eissa, MM Khalifa, EB Elkaeed, EE Hafez, AA Alsfouk, AM Metwaly Molecules 26 (20), 6151, 2021 | 52 | 2021 |
| Multi-step in silico discovery of natural drugs against COVID-19 targeting main protease EB Elkaeed, FS Youssef, IH Eissa, H Elkady, AA Alsfouk, ML Ashour, ... International Journal of Molecular Sciences 23 (13), 6912, 2022 | 47 | 2022 |
| In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking … MS Alesawy, EB Elkaeed, AA Alsfouk, AM Metwaly, IH Eissa Molecules 26 (21), 6593, 2021 | 46 | 2021 |
| The Assessment of Anticancer and VEGFR-2 Inhibitory Activities of a New 1H-Indole Derivative: In Silico and In Vitro Approaches EB Elkaeed, RG Yousef, H Elkady, IMM Gobaara, AA Alsfouk, DZ Husein, ... Processes 10 (7), 1391, 2022 | 43 | 2022 |
| A multistage in silico study of natural potential inhibitors targeting SARS-CoV-2 main protease EB Elkaeed, IH Eissa, H Elkady, A Abdelalim, AM Alqaisi, AA Alsfouk, ... International Journal of Molecular Sciences 23 (15), 8407, 2022 | 41 | 2022 |
| Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: Virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic … RG Yousef, A Ibrahim, MM Khalifa, WM Eldehna, IMM Gobaara, ... Journal of enzyme inhibition and medicinal chemistry 37 (1), 1389-1403, 2022 | 37 | 2022 |
| Modified benzoxazole-based VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, and anti-proliferative evaluation A Elwan, AE Abdallah, HA Mahdy, MA Dahab, MS Taghour, EB Elkaeed, ... Molecules 27 (15), 5047, 2022 | 33 | 2022 |
| Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation MS Taghour, HA Mahdy, MH Gomaa, A Aglan, MG Eldeib, A Elwan, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 2063-2077, 2022 | 30 | 2022 |
| New Anticancer Theobromine Derivative Targeting EGFRWT and EGFRT790M: Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies EB Elkaeed, RG Yousef, H Elkady, AA Alsfouk, DZ Husein, IM Ibrahim, ... Molecules 27 (18), 5859, 2022 | 30 | 2022 |
| Topographical mapping of isoform-selectivity determinants for J-channel-binding inhibitors of sphingosine kinases 1 and 2 DR Adams, S Tawati, G Berretta, PL Rivas, J Baiget, Z Jiang, A Alsfouk, ... Journal of Medicinal Chemistry 62 (7), 3658-3676, 2019 | 29 | 2019 |
| Isolation and In Silico Anti-SARS-CoV-2 Papain-Like Protease Potentialities of Two Rare 2-Phenoxychromone Derivatives from Artemisia spp. YM Suleimen, RA Jose, RN Suleimen, C Arenz, M Ishmuratova, S Toppet, ... Molecules 27 (4), 1216, 2022 | 28 | 2022 |
| 3D-QSAR, ADME-Tox in silico prediction and molecular docking studies for modeling the analgesic activity against neuropathic pain of novel NR2B-selective NMDA receptor antagonists M El fadili, M Er-rajy, H Imtara, M Kara, S Zarougui, N Altwaijry, ... Processes 10 (8), 1462, 2022 | 27 | 2022 |
| Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy A Alsfouk Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 693-706, 2021 | 24 | 2021 |
| Isolation and In Silico SARS-CoV-2 Main Protease Inhibition Potential of Jusan Coumarin, a New Dicoumarin from Artemisia glauca YM Suleimen, RA Jose, RN Suleimen, MY Ishmuratova, S Toppet, ... Molecules 27 (7), 2281, 2022 | 20 | 2022 |
| Discovery of potential SARS-CoV-2 papain-like protease natural inhibitors employing a multi-phase in silico approach EB Elkaeed, AM Metwaly, MS Alesawy, AM Saleh, AA Alsfouk, IH Eissa Life 12 (9), 1407, 2022 | 19 | 2022 |
| Pharmacological outcomes in teenagers with newly diagnosed epilepsy: A 30‐year cohort study BA Alsfouk, AA Alsfouk, Z Chen, P Kwan, MJ Brodie Epilepsia 60 (6), 1083-1090, 2019 | 16 | 2019 |
| Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and apoptosis inducers IH Eissa, RG Yousef, H Elkady, EB Elkaeed, AA Alsfouk, DZ Husein, ... Computational Biology and Chemistry 107, 107953, 2023 | 14 | 2023 |
| Combined in silico and experimental investigations of resveratrol encapsulation by beta-cyclodextrin A Iskineyeva, S Fazylov, R Bakirova, A Sarsenbekova, I Pustolaikina, ... Plants 11 (13), 1678, 2022 | 14 | 2022 |
